Dan C. Tong-Castillo

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.

Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.

Journal: Annals of surgical oncology

Published: September 30, 2021

Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer.

Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer.

Journal: Cancers

Published: October 26, 2020

Gene Expression of Kallikreins in Breast Cancer Cell Lines.

Gene Expression of Kallikreins in Breast Cancer Cell Lines.

Journal: Anticancer research

Published: March 22, 2020

Metabolism of Estrogens: Turnover Differs Between Platinum-Sensitive and -Resistant High-Grade Serous Ovarian Cancer Cells.

Metabolism of Estrogens: Turnover Differs Between Platinum-Sensitive and -Resistant High-Grade Serous Ovarian Cancer Cells.

Journal: Cancers

Published: December 09, 2019

USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability.

USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability.

Journal: Science advances

Published: September 05, 2018

Gene expression information improves reliability of receptor status in breast cancer patients.

Gene expression information improves reliability of receptor status in breast cancer patients.

Journal: Oncotarget

Published: April 12, 2017

Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium.

Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium.

Journal: Oncotarget

Published: November 01, 2016

Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer.

Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer.

Journal: Oncology letters

Published: September 13, 2016

Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer.

Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 11, 2016

Corrigendum to "Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer" [Eur J Cancer 53 (2016) 51-64].

Corrigendum to "Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer" [Eur J Cancer 53 (2016) 51-64].

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 24, 2016

HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.

HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.

Journal: Anticancer research

Published: December 06, 2015

HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.

HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.

Journal: Anticancer research

Published: October 28, 2015

Showing 1-12 of 29

Last Updated: 09/26/2026